Sotagliflozin (CED0006060)

Record Information

Version

1.0

Creation Date

2026-04-14 19:00:41 UTC

Update Date

2026-08-21 19:07:48 UTC

Accession Number

CHEM131680

Identification

Common Name

Sotagliflozin

Class

Small Molecule

Description

Sotagliflozin is an organic compound with the formula C21H25ClO5S and an average molecular weight of 424.94 g/mol. Sotagliflozin belongs to the carbohydrates and carbohydrate conjugates, a subclass of organooxygen compounds within the organic compounds. This compound is used in healthcare, pharmaceuticals, and veterinary products as a blood glucose lowering drug, excluding insulins, and is administered via the oral exposure route. It acts as an inhibitor of two protein targets: Sodium/glucose cotransporter 1 (SLC5A1) and Sodium/glucose cotransporter 2 (SLC5A2).

Contaminant Type

Not Available

Chemical Structure

MOL SDF PDB SMILES InChI

Synonyms

Not Available

Chemical Formula

C₂₁H₂₅ClO₅S

Average Molecular Mass

424.940 g/mol

Monoisotopic Mass

424.111 g/mol

CAS Registry Number

1018899-04-1

IUPAC Name

Not Available

Traditional Name

Not Available

SMILES

CCOC1=CC=C(CC2=CC(=CC=C2Cl)[C@@H]2O[C@H](SC)[C@@H](O)[C@H](O)[C@H]2O)C=C1

InChI Identifier

InChI=1S/C21H25ClO5S/c1-3-26-15-7-4-12(5-8-15)10-14-11-13(6-9-16(14)22)20-18(24)17(23)19(25)21(27-20)28-2/h4-9,11,17-21,23-25H,3,10H2,1-2H3/t17-,18-,19+,20+,21-/m1/s1

InChI Key

QKDRXGFQVGOQKS-CRSSMBPESA-N

Chemical Taxonomy

Classification

Not classified

Biological Properties

Status

Detected and Not Quantified

Origin

Not Available

Cellular Locations

Not Available

Biofluid Locations

Not Available

Tissue Locations

Not Available

Applications

Not Available

Biological Roles

Not Available

Chemical Roles

Not Available

Organoleptic Effects

Not Available

Physical Properties

State

Not Available

Appearance

Not Available

Experimental Properties

Property	Value
Melting Point	Not Available
Boiling Point	Not Available
Solubility	Not Available

Predicted Properties

Not Available

Spectra

Spectrum Type	Description	Splash Key	Deposition Date	View
Predicted LC-MS/MS	Predicted LC-MS/MS Spectrum	splash10-004r-0623900000-520355d28117e7256dc7	Not Available	View Spectrum
Predicted LC-MS/MS	Predicted LC-MS/MS Spectrum	splash10-004i-1839400000-bf2cde507e92f1ec8a2d	Not Available	View Spectrum
Predicted LC-MS/MS	Predicted LC-MS/MS Spectrum	splash10-0012-0690000000-ae936e7bcd5267d8eb3a	Not Available	View Spectrum
Predicted LC-MS/MS	Predicted LC-MS/MS Spectrum	splash10-0fka-9238300000-5fb79972ce56ef7d91ae	Not Available	View Spectrum
Predicted LC-MS/MS	Predicted LC-MS/MS Spectrum	splash10-05fs-9022000000-e0ce79c52c67cf3e5cda	Not Available	View Spectrum
Predicted LC-MS/MS	Predicted LC-MS/MS Spectrum	splash10-0005-9046000000-cca4bce2d33191382b06	Not Available	View Spectrum

Toxicity Profile

Mechanism of Toxicity

Not Available

Carcinogenicity (IARC Classification)

Not Available

Minimum Risk Level

Not Available

Symptoms

Not Available

Treatment

Not Available

Toxicity Values

Toxicity Value	Unit	Value Range	Organism	Dose Descriptor	Route of Exposure	Predicted or Experimental	Reference
1851.0	Log mg/kg	[1000:3300]	Rat	LD50	oral	predicted	Not Available

Health Effects

Health Effect	Relationship	Direction	Reference

Exposure Sources

Source ID	Source	Sector	Reference
263	Blood glucose lowering drugs, excl. insulins	Healthcare, pharmaceuticals & veterinary products	Not Available

Pathways

1 pathway

Sotagliflozin Drug Metabolism Action Pathway

Targets

Structure	Protein	UniProt ID	Organism	Relationship	Details
Click to view 3D structure	Cytochrome P450 1A2	P05177	Humans	Predicted (SEA)	4354.57
Click to view 3D structure	Cannabinoid receptor 2	P34972	Humans	Predicted (SEA)	1392.02
Click to view 3D structure	Glycogen synthase kinase-3 beta	P49841	Humans	Predicted (SEA)	4602.68
Click to view 3D structure	Trehalose-phosphatase	A8NS89	Brugia malayi	Predicted (SEA)	25.2231
Click to view 3D structure	Dual specificity protein kinase CLK4	Q9HAZ1	Humans	Predicted (SEA)	3867.71
Click to view 3D structure	Nitric oxide synthase 1	P29475	Humans	Predicted (SEA)	133.356
Click to view 3D structure	Amine oxidase [flavin-containing] B	P19643	Rattus norvegicus	Predicted (SEA)	557.245
Click to view 3D structure	5-hydroxytryptamine receptor 2A	P28223	Humans	Predicted (SEA)	4035.31
Click to view 3D structure	Histamine H1 receptor	P35367	Humans	Predicted (SEA)	2987.62
Click to view 3D structure	Dual specificity protein kinase CLK2	P49760	Humans	Predicted (SEA)	4110.91
Click to view 3D structure	Sodium/glucose cotransporter 2	P31639	Humans	Predicted (SEA)	0.0778492
Click to view 3D structure	Sodium/glucose cotransporter 2	Q923I7	Mus musculus	Predicted (SEA)	0.233548
Click to view 3D structure	Sodium/glucose cotransporter 1	P13866	Humans	Predicted (SEA)	0.155698
Click to view 3D structure	Sodium/myo-inositol cotransporter 2	Q8WWX8	Humans	Predicted (SEA)	0.544945
Click to view 3D structure	Sodium/glucose cotransporter 2	P53792	Rattus norvegicus	Predicted (SEA)	0.622794
Click to view 3D structure	Ceramide synthase 1	P27545	Mus musculus	Predicted (SEA)	13.0787
Click to view 3D structure	Ceramide synthase 4	Q9HA82	Humans	Predicted (SEA)	13.0787
Click to view 3D structure	Ceramide synthase 6	Q6ZMG9	Humans	Predicted (SEA)	13.0787
Click to view 3D structure	Ceramide synthase 2	Q924Z4	Mus musculus	Predicted (SEA)	13.0787
Click to view 3D structure	Ceramide synthase 5	Q9D6K9	Mus musculus	Predicted (SEA)	13.0787
Click to view 3D structure	Ceramide synthase 1	P27544	Humans	Predicted (SEA)	13.0787
Click to view 3D structure	Sphingosine 1-phosphate receptor 1	P21453	Humans	Predicted (SEA)	692.391
Click to view 3D structure	Sphingosine 1-phosphate receptor 5	Q9H228	Humans	Predicted (SEA)	406.139
Click to view 3D structure	Mu-type opioid receptor	P35372	Humans	Predicted (SEA)	2545.98
Click to view 3D structure	Amine oxidase [flavin-containing] A	P21396	Rattus norvegicus	Predicted (SEA)	371.107